Balloon in artery to reduce blood loss during c-section for placenta accreta
Part of Women’s health & pregnancy clinical trials.
This trial tests whether a balloon placed in a major artery (REBOA) can help reduce dangerous blood loss during cesarean delivery for women with placenta accreta. If you have this condition and are planning a c-section at 34 weeks or more, this study may offer an extra safety measure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 34 weeks pregnant with a single baby (not twins or more).
- You have been diagnosed with placenta accreta spectrum (a condition where the placenta attaches too deeply).
- You are planning to have a scheduled (not emergency) c-section.
- You are between 18 and 45 years old.
- You do not have a known bleeding disorder or abnormal blood clotting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two methods (a cervical tourniquet and tying off the uterine artery) to control bleeding during a c-section for women with placenta accreta. If you are having an elective c-section at 36 weeks or later for this condition, this trial may help reduce blood loss.
This trial tests if giving a special medication during surgery can help reduce blood loss in women with a condition called PAS (where the placenta grows too deeply into the uterus) who are having a C-section and their uterus removed. It may make the surgery safer.
This trial studies what happens after a planned C-section when placenta accreta spectrum is diagnosed by ultrasound and the uterus is kept. It may help doctors understand the safest way to manage this condition and what outcomes to expect.
This trial is studying a new approach to prevent and treat a pregnancy complication called placenta accreta spectrum (where the placenta grows too deeply into the uterus). It aims to help pregnant women diagnosed with this condition improve their outcomes.
This trial tests a specialized surgical technique to treat placenta accreta spectrum (a serious condition where the placenta grows too deeply into the uterus) while preserving your uterus instead of removing it. The goal is to help you keep your ability to have future pregnancies.
This study compares three different surgical methods to safely treat placenta accreta spectrum, a condition where the placenta grows too deeply into the uterus. The goal is to find which approach works best with fewer complications.
Hear when a new Placenta Accreta Spectrum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.